G6Pase Antibodies

Santa Cruz Biotechnology features a diverse variety of G6Pase Antibodies for research in understanding glucose metabolism and regulation. G6Pase Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glucose-6-phosphatase (G6Pase) plays a critical role in gluconeogenesis and glycogenolysis, processes essential for maintaining blood glucose levels. Dysregulation of G6Pase activity is associated with metabolic disorders, including diabetes and glycogen storage diseases, making it a significant target for research. Understanding the function and regulation of G6Pase is vital for developing therapeutic strategies aimed at these conditions. G6Pase research has revealed important insights into metabolic pathways and their regulation in various physiological states. Investigating G6Pase expression patterns helps researchers better understand glucose homeostasis and its disruption in disease states. The role of G6Pase in energy metabolism continues to be an active area of investigation, with new findings emerging regularly. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of glucose metabolism and its impact on human health.